Related Experiment Video
Updated: May 14, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
An update on viral association of human cancers
Xiangning Zhang1, Zhe Zhang, Biying Zheng
1Department of Pathophysiology, and Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Sino-American Cancer Research Institute, Guangdong Medical College, Dongguan, Guangdong, China. zhangxn_2006@126.com
Abstract:
Up to now, seven viruses that infect humans have been identified as oncogenic and are closely associated with different human cancers. Most of them encode oncogenes whose products play important roles in the development of cancers in the context of environmental and genetic factors; others may act via indirect mechanisms. The transforming activities of the human oncogenic viruses have much in common with the well-studied tumorigenic processes elicited by the acutely transforming murine retroviruses. Many of these mechanisms have been elucidated for or are represented in the successive steps leading to the efficient in vitro immortalization by the lymphotropic herpesvirus Epstein-Barr virus, although the establishment of malignancy in vivo takes longer. The development of cancer is a complicated process involving multiple factors, from the host and the environment. Although any one of these etiologic factors may exert an effect on the carcinogenic process, vaccination against the viral pathogen in several cases has shown efficacy in preventing the spread of the virus and, in turn, the development of the associated cancers. Modern laboratory techniques can be expected to facilitate the identification of new emerging viruses whose association with malignancies is suggested by epidemiologic and clinical data.
Insights
Seven human oncogenic viruses are linked to cancer, often through oncogenes. Vaccination can prevent some virus-associated cancers, and new techniques may identify more oncogenic viruses.
Area of Science:
- Virology
- Oncology
- Cancer Research
Background:
- Seven human viruses are known oncogenic agents, implicated in various human cancers.
- Oncogenic viruses contribute to cancer development via oncogenes or indirect mechanisms.
- Viral oncogenesis shares similarities with murine retrovirus-induced tumorigenesis.
Purpose of the Study:
- To review the role of oncogenic viruses in human cancer development.
- To highlight common mechanisms between viral and murine oncogenesis.
- To discuss the potential of vaccination and new technologies in combating virus-associated cancers.
Main Methods:
- Literature review of oncogenic viruses and their mechanisms.
- Comparison of human and murine viral oncogenesis pathways.
- Discussion of host, environmental, and viral factors in cancer development.
Main Results:
- Oncogenic viruses encode proteins that drive cancer progression.
- Epstein-Barr virus exemplifies viral immortalization mechanisms.
- Cancer development is multifactorial, involving host and environmental elements.
Conclusions:
- Vaccination against certain viruses can prevent associated cancers.
- Advanced laboratory techniques aid in identifying novel oncogenic viruses.
- Understanding viral oncogenesis is crucial for cancer prevention and treatment.
More Related Videos
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell